473258-20-7 Usage
Chemical structure
The compound consists of an ethylpropionate group attached to a hydrazine group with a 3,4-difluorophenyl substitution.
Usage
It is commonly used in the synthesis of various pharmaceuticals and organic compounds.
Biological and pharmacological activities
The compound has potential biological and pharmacological activities and is being studied for its potential medical applications.
Medical applications
It is particularly being studied for its potential use in the treatment of neurological and psychiatric disorders.
Importance in research
Its unique chemical structure and properties make it an interesting target for further research and development in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 473258-20-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,2,5 and 8 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 473258-20:
(8*4)+(7*7)+(6*3)+(5*2)+(4*5)+(3*8)+(2*2)+(1*0)=157
157 % 10 = 7
So 473258-20-7 is a valid CAS Registry Number.
473258-20-7Relevant academic research and scientific papers
Indole derivative and medical application thereof
-
Paragraph 0557-0561, (2020/12/15)
The invention discloses an indole compound with FABP4/5 inhibitory activity and a preparation method and medical application of the indole compound. The indole compound is a compound of which the structural formula is shown as a formula I, and pharmaceutically acceptable salt or ester or solvate of the compound. The compound shown in the formula I is a novel FABP4/5 inhibitor and can be used for preparing medicines for preventing or treating FABP4/5 related diseases.
Phenylindoles for the treatment of HIV
-
, (2008/06/13)
The invention as disclosed herein is a method and composition for the treatment of HIV in humans and other host animals, that includes the administration of an effective HIV treatment amount of a phenylindole as described herein or a pharmaceutically acce
